Remedium Lifecare Ratios

Remedium Lifecare Ltd Ratios

The Remedium Lifecare Ltd Ratios page provides a complete fundamental analysis of Remedium Lifecare Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Remedium Lifecare Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Remedium Lifecare Ltd (NSE: , BSE: 539561) is currently trading at ₹0.37, with a market capitalization of ₹326.34M. As a major player in the Consumer durables sector and Motor vehicles industry, Remedium Lifecare Ltd remains a key stock for fundamental analysis using Remedium Lifecare Ltd Ratios.

Remedium Lifecare Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Remedium Lifecare Ltd P/E ratio currently stands at 34.43, making it one of the most tracked metrics in Remedium Lifecare Ltd Ratios.

Historically, the Remedium Lifecare Ltd P/E ratio has shown strong fluctuations:

• 2024: 34.43
• 2023: 33.42
• 2022: 48.95
• 2021: 46.16
• 2020: 33.04

The rising Remedium Lifecare Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Remedium Lifecare Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 1.67.

Historical P/B trend:

• 2024: 1.67
• 2023: 25.46
• 2022: 25.62
• 2021: 10.10

Remedium Lifecare Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Remedium Lifecare Ltd P/S ratio currently stands at 0.18, an important part of Remedium Lifecare Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 0.18
• 2023: 0.27
• 2022: 0.52
• 2021: 0.10

A stable or declining Remedium Lifecare Ltd P/S ratio indicates cautious market sentiment.

Remedium Lifecare Ltd Price to Cash Flow Ratio (P/CF)

The Remedium Lifecare Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Remedium Lifecare Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 0
• 2022: 12.98
• 2021: 4.46
• 2020: 0

The declining Remedium Lifecare Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Remedium Lifecare Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Remedium Lifecare Ltd EV currently stands at ₹12.11B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 12.11B
• 2023: 11.48B
• 2022: 2.44B
• 2021: 484.24M

Remedium Lifecare Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Remedium Lifecare Ltd EV/EBITDA ratio is currently 0, a key metric in Remedium Lifecare Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 33.57
• 2022: 33.86
• 2021: 57.95

Stable Remedium Lifecare Ltd EV/EBITDA indicates balanced valuation.

Remedium Lifecare Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Remedium Lifecare Ltd D/E ratio is currently 26.01, reflecting leverage and financial stability.

Historical D/E:

• 2024: 26.01
• 2023: 1.34
• 2022: 0
• 2021: 0

Higher D/E ratio indicates rising financial risk.

Return on Equity (ROE %)

The Remedium Lifecare Ltd ROE currently stands at 4.90%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 4.90
• 2023: 122.76
• 2022: 70.92
• 2021: 24.51

Declining ROE indicates pressure on profitability.

Remedium Lifecare Ltd Ratios Analysis Summary

The Remedium Lifecare Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Remedium Lifecare Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Remedium Lifecare Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.